Skip to main content
Erschienen in: Infection 3/2017

13.03.2017 | Review

The “Choosing Wisely” initiative in infectious diseases

verfasst von: Clara Lehmann, Reinhard Berner, Johannes R. Bogner, Oliver A. Cornely, Katja de With, Susanne Herold, Winfried V. Kern, Sebastian Lemmen, Mathias W. Pletz, Bernhard Ruf, Bernd Salzberger, Hans Jürgen Stellbrink, Norbert Suttorp, Andrew J. Ullmann, Gerd Fätkenheuer, Norma Jung

Erschienen in: Infection | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

“Choosing Wisely” is a growing international campaign aiming at practice changes to improve patient health and safety by both, conduct of essential and avoidance of unnecessary diagnostic, preventive and therapeutic procedures. The goal is to create an easily recognizable and distributable list (“Choosing Wisely items”) that addresses common over- and underuse in the management of infectious diseases.

Methods

The German Society of Infectious Diseases (DGI) participates in the campaign “Klug Entscheiden” by the German Society of Internal Medicine. Committee members of the (DGI) listed potential ‘Choosing Wisely items’. Topics were subjected to systematic evidence review and top ten items were selected for appropriateness. Five positive and negative recommendations were approved via individual member vote.

Results

The final recommendations are: (1) Imperatively start antimicrobial treatment and remove the focus in Staphylococcus aureus bloodstream infection. (2) Critically ill patients with signs of infection need early appropriate antibiotic therapy. (3) Annual influenza vaccination should be given to individuals with age >60 years, patients with specific co-morbidities and to contact persons who may spread influenza to others. (4) All children should receive measles vaccine. (5) Prefer oral formulations of highly bioavailable antimicrobials whenever possible. (6) Avoid prescribing antibiotics for uncomplicated upper respiratory tract infections. (7) Do not treat asymptomatic bacteriuria with antibiotics. (8) Do not treat Candida detected in respiratory or gastrointestinal tract specimens. (9) Do not prolong prophylactic administration of antibiotics in patients after they have left the operating room. (10) Do not treat an elevated C-reactive protein (CRP) or procalcitonin with antibiotics for patients without signs of infection.

Conclusions

Physicians will reduce potential harm to patients and increase the value of health care when implementing these recommendations.
Literatur
1.
Zurück zum Zitat Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242–51.CrossRefPubMed Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242–51.CrossRefPubMed
2.
Zurück zum Zitat López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57:1225–33.CrossRefPubMed López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57:1225–33.CrossRefPubMed
3.
Zurück zum Zitat Fries BL, Licitra C, Crespo A, et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2014;58:598–9.CrossRefPubMed Fries BL, Licitra C, Crespo A, et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2014;58:598–9.CrossRefPubMed
4.
Zurück zum Zitat Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11:208–22.CrossRefPubMed Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11:208–22.CrossRefPubMed
6.
Zurück zum Zitat Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12:919–24.CrossRefPubMed Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12:919–24.CrossRefPubMed
7.
Zurück zum Zitat Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.CrossRefPubMed
8.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.CrossRefPubMed Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.CrossRefPubMed
9.
Zurück zum Zitat Bödeker B, Remschmidt C, Schmich P, Wichmann O. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health. 2015;15:618.CrossRefPubMedPubMedCentral Bödeker B, Remschmidt C, Schmich P, Wichmann O. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health. 2015;15:618.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Uyeki TM. Preventing and controlling influenza with available interventions. N Engl J Med. 2014;370:789–91.CrossRefPubMed Uyeki TM. Preventing and controlling influenza with available interventions. N Engl J Med. 2014;370:789–91.CrossRefPubMed
12.
Zurück zum Zitat Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–9.CrossRefPubMedPubMedCentral Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–9.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012;CD004407. Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012;CD004407.
16.
Zurück zum Zitat MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis. 1997;24:457–67.CrossRefPubMed MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis. 1997;24:457–67.CrossRefPubMed
17.
Zurück zum Zitat Nathwani D, Lawson W, Dryden M, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21:S47–55.CrossRefPubMed Nathwani D, Lawson W, Dryden M, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21:S47–55.CrossRefPubMed
18.
Zurück zum Zitat Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014;69:234–40.CrossRefPubMed Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014;69:234–40.CrossRefPubMed
19.
20.
Zurück zum Zitat Hersh AL, Jackson MA, Hicks LA. Diseases AAoPCoI. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013;132:1146–54.CrossRefPubMed Hersh AL, Jackson MA, Hicks LA. Diseases AAoPCoI. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013;132:1146–54.CrossRefPubMed
21.
Zurück zum Zitat Zalmanovici trestioreanu A, Lador A, Sauerbrun-Cutler MT, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015;4:534. Zalmanovici trestioreanu A, Lador A, Sauerbrun-Cutler MT, Leibovici L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. 2015;4:534.
22.
Zurück zum Zitat Weiskopf J, Scott S. Asymptomatic bacteriuria, what are you treating? JAMA Intern Med. 2015;175:344–5.CrossRefPubMed Weiskopf J, Scott S. Asymptomatic bacteriuria, what are you treating? JAMA Intern Med. 2015;175:344–5.CrossRefPubMed
23.
Zurück zum Zitat Nicolle LE. Management of asymptomatic bacteriuria in pregnant women. Lancet Infect Dis. 2015;15:1252–4.CrossRefPubMed Nicolle LE. Management of asymptomatic bacteriuria in pregnant women. Lancet Infect Dis. 2015;15:1252–4.CrossRefPubMed
24.
Zurück zum Zitat Coussement J, Abramowicz D. Should we treat asymptomatic bacteriuria after renal transplantation? Nephrol Dial Transplant. 2014;29:260–2.CrossRefPubMed Coussement J, Abramowicz D. Should we treat asymptomatic bacteriuria after renal transplantation? Nephrol Dial Transplant. 2014;29:260–2.CrossRefPubMed
25.
Zurück zum Zitat Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med. 2009;35:1526–31.CrossRefPubMed Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med. 2009;35:1526–31.CrossRefPubMed
26.
Zurück zum Zitat Lindau S, Nadermann M, Ackermann H, et al. Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects. J Intensive Care. 2015;3:31.CrossRefPubMedPubMedCentral Lindau S, Nadermann M, Ackermann H, et al. Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects. J Intensive Care. 2015;3:31.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18:19–37.CrossRefPubMed Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18:19–37.CrossRefPubMed
28.
Zurück zum Zitat Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.CrossRefPubMed Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.CrossRefPubMed
29.
Zurück zum Zitat ten Oever J, Netea MG, Kullberg BJ. Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect. 2016;72:1–18.CrossRefPubMed ten Oever J, Netea MG, Kullberg BJ. Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect. 2016;72:1–18.CrossRefPubMed
30.
Zurück zum Zitat Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford). 2008;47:1780–4.CrossRefPubMed Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford). 2008;47:1780–4.CrossRefPubMed
31.
Zurück zum Zitat Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.CrossRefPubMed Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.CrossRefPubMed
32.
Zurück zum Zitat Auer J, Berent R, Eber B, et al. C-reactive protein in patients with acute myocardial infarction. Circulation. 2004;109:E20.CrossRefPubMed Auer J, Berent R, Eber B, et al. C-reactive protein in patients with acute myocardial infarction. Circulation. 2004;109:E20.CrossRefPubMed
33.
Zurück zum Zitat Morden NE, Colla CH, Sequist TD, Rosenthal MB. Choosing wisely–the politics and economics of labeling low-value services. N Engl J Med. 2014;370:589–92.CrossRefPubMedPubMedCentral Morden NE, Colla CH, Sequist TD, Rosenthal MB. Choosing wisely–the politics and economics of labeling low-value services. N Engl J Med. 2014;370:589–92.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Wolfson D, Santa J, Slass L. Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med. 2014;89:990–5.CrossRefPubMed Wolfson D, Santa J, Slass L. Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med. 2014;89:990–5.CrossRefPubMed
35.
Zurück zum Zitat Jung N, Lehmann C, Fätkenheuer G. The, “Choosing Wisely”: initiative in infectious diseases. Infection. 2016;44:283–90.CrossRefPubMed Jung N, Lehmann C, Fätkenheuer G. The, “Choosing Wisely”: initiative in infectious diseases. Infection. 2016;44:283–90.CrossRefPubMed
Metadaten
Titel
The “Choosing Wisely” initiative in infectious diseases
verfasst von
Clara Lehmann
Reinhard Berner
Johannes R. Bogner
Oliver A. Cornely
Katja de With
Susanne Herold
Winfried V. Kern
Sebastian Lemmen
Mathias W. Pletz
Bernhard Ruf
Bernd Salzberger
Hans Jürgen Stellbrink
Norbert Suttorp
Andrew J. Ullmann
Gerd Fätkenheuer
Norma Jung
Publikationsdatum
13.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 3/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-0997-0

Weitere Artikel der Ausgabe 3/2017

Infection 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.